Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orion Animal Health is a specialized division of the Finnish pharmaceutical company Orion Corporation, focusing on the development, manufacture, and marketing of veterinary medicines and care products. The company is a global leader in veterinary sedative and analgesic products, particularly known for its proprietary alpha-2 adrenoceptor agonists used in both companion animals and livestock. Their portfolio includes innovative treatments for canine anxiety, such as noise-induced fear and separation anxiety, alongside a broad range of generic veterinary pharmaceuticals. Orion Animal Health operates internationally, with a strong presence in the Nordic markets and extensive distribution partnerships globally, including a long-standing collaboration with Zoetis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orion Animal Health.